You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

21 August 2017

Better patient communication gets more people admitting adherence issues

A pilot that saw health workers adopt ‘patient-centred’ communication at an HIV clinic in rural Tanzania led to a three-fold increase in the number of people openly reporting treatment adherence problems.

03 August 2017

Injectable antiretroviral drugs – a ‘remarkable milestone’

Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV

20 July 2017

HIV drug resistance is rising and needs urgent attention, says World Health Organization

Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.

28 June 2017

HIV wonder drug dolutegravir to be rolled-out in Kenya

UNITAID partners to bring newer and more effective HIV treatment options to countries where they are needed most.

22 June 2017

PrEP now included on the WHO Essential Medicines List

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

03 May 2017

India to provide free treatment for all people living with HIV

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

16 March 2017

Nanomedicine could reduce dose and cost of treatment for people living with HIV, early trials show

The first trials enhancing orally-taken antiretroviral treatment with Solid Drug Nanoparticle technology have produced “incredibly promising” results.

03 March 2017

Decentralised antiretroviral treatment delivery in an urban setting – a Kinshasa success

The first ever study evaluating the decentralising of HIV care through antiretroviral treatment (ART) distribution centres shows low rates of patient loss in the city.

21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

14 February 2017

HIV self-testing a useful tool for pre-exposure prophylaxis (PrEP) delivery in Kenya

Mixed-status couples using PrEP could benefit from HIV self-testing as a way to quickly diagnose any new infections and reduce frequency of clinic visits.